Pharmacotherapics Advice in Guidelines for COVID-19
Since December 2019 to May 2020, coronavirus disease 2019 (COVID-19) has infected over 6 million people worldwide. Due to its sudden and rapid outbreak, effective treatment for COVID-19 is scarce. Based on national clinical trials of novel treatments, China, Italy, Germany, and other countries and o...
Saved in:
Main Authors: | Zhang-Ren Chen (Author), Ying Zhou (Author), Jin Liu (Author), Hong-Wei Peng (Author), Jian Zhou (Author), Hai-Li Zhong (Author), Li-Li Liu (Author), Ming-Fang Lai (Author), Xiao-Hua Wei (Author), Jin-Hua Wen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
by: Na Lin, et al.
Published: (2021) -
Technical guidelines for risk assessment of heavy metals in traditional Chinese medicines
by: Tian-Tian Zuo, et al.
Published: (2023) -
A qualitative study of the experiences of interdisciplinary nurses during the COVID-19 outbreak following the announcement of the "Ten new guidelines" in China
by: Li-Li Huang, et al.
Published: (2024) -
Guidelines for the Diagnosis and Treatment of Rosacea in China (2021 Edition)#
by: Rosacea Research Center, Chinese Society of Dermatology; Rosacea Professional Committee, Chinese Dermatologist Association, et al.
Published: (2021) -
Baicalein Enhances the Oral Bioavailability and Hepatoprotective Effects of Silybin Through the Inhibition of Efflux Transporters BCRP and MRP2
by: Peng Xu, et al.
Published: (2018)